← All trials
NCT05220787
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2022
- Primary completion
- Oct 29, 2024
- Completion date
- Oct 29, 2024
- First posted
- Feb 2, 2022
- Last posted
- Feb 2, 2022
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bloodworks NorthwestLead sponsor
- Department of DefenseCollaborator
- Bloodworks NorthwestOverall official - principal investigator
- Bloodworks NorthwestSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.